oridonin

N/A

Report date: 2026/04/15 20:02:38
NME

Base Information

Drug Nameoridonin
Drug Alias NameYXZ-01
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionNACHT, LRR and PYD domains-containing protein 3 inhibitorsSerine/threonine-protein kinase AKT1 modulators
TargetsNACHT, LRR and PYD domains-containing protein 3Serine/threonine-protein kinase AKT1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesSinopharm A-Think Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSinopharm A-Think Pharmaceutical Co LtdTsinghua University
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A